primary systemic amyloidosis
Showing 1 - 14 of 14
Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,
Active, not recruiting
- Light Chain Deposition Disease
- Primary Systemic Amyloidosis
- pomalidomide
- +3 more
-
Denver, Colorado
- +4 more
Jan 20, 2023
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea Trial in United States (Isatuximab, Laboratory Biomarker
Active, not recruiting
- Amorphous, Eosinophilic, and Acellular Deposit
- +12 more
- Isatuximab
- Laboratory Biomarker Analysis
-
Anchorage, Alaska
- +344 more
Aug 22, 2022
Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in United States (melphalan, dexamethasone, bortezomib)
Completed
- Light Chain Deposition Disease
- Primary Systemic Amyloidosis
- melphalan
- +2 more
-
Scottsdale, Arizona
- +208 more
Jan 12, 2022
Primary Systemic Amyloidosis Trial in Milwaukee (Doxycycline)
Completed
- Primary Systemic Amyloidosis
-
Milwaukee, WisconsinFroedtert & Medical College of Wisconsin
Jun 18, 2021
Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in
Completed
- Acute Undifferentiated Leukemia
- +63 more
- total-body irradiation
- +7 more
-
Seattle, Washington
- +1 more
Jan 17, 2020
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic
Completed
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
- +76 more
- fludarabine phosphate
- +6 more
-
Tucson, Arizona
- +10 more
Jan 17, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +178 more
- fludarabine phosphate
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
Primary Systemic Amyloidosis Trial in Spain (Lenalidomide, Cyclophosphamide, Dexamethasone)
Completed
- Primary Systemic Amyloidosis
- Lenalidomide
- +2 more
-
Tenerife, Islas Canarias, Spain
- +9 more
Apr 23, 2017
Primary Systemic Amyloidosis Trial in Rochester (bortezomib, cyclophosphamide, dexamethasone)
Completed
- Primary Systemic Amyloidosis
- bortezomib
- +2 more
-
Rochester, MinnesotaMayo Clinic
Mar 5, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +80 more
- imatinib mesylate
- pharmacological study
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 6, 2013
Primary Systemic Amyloidosis Trial in Rochester (4'-iodo-4'-deoxydoxorubicin, pharmacological study)
Terminated
- Primary Systemic Amyloidosis
- 4'-iodo-4'-deoxydoxorubicin
- pharmacological study
-
Rochester, MinnesotaMayo Clinic
Jan 15, 2013